Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
Recruiting
Observational Study
BRCA Mutation
Ovarian Cancer
Ultrasound Therapy; Complications
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 6,465 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The project aims at enhancing performance metrics and prospectively validating a radiogenomics model based on ovarian US images for predicting germline breast cancer susceptibility gene 1 and/or 2 (BRCA) status in women with healthy ovaries. The project is divided in two operational phases:
Model development phase (ambispective)
AIM 1: To define and implement a proper and fine-tuned image prepro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Availability of gBRCA1/2 test results
Transvaginal pelvic US performed providing at least one picture of one healthy ovary
US images stored in .dicom format.
Exclusion Criteria:
Personal diagnosis of OC
Ovarian abnormal findings (eg. ovarian endometriomas, dermoid cyst, ova…
Contacts